RPAM
FWP

Rhenman & Partners Asset Management’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

Rhenman & Partners Asset Management’s Portfolio FWP Stock Details FWP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,226
Closed -$744K – 115
2017
Q2 		$744K Buy
+5,226
New +$727K 0.11% 87

Other funds holding FWP

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rhenman & Partners Asset Management's FWP Position: Q3 2017 in Review

Rhenman & Partners Asset Management sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q3 2017, closing a stake of 5,226 shares — an estimated $744K sold.

Rhenman & Partners Asset Management first reported a position in FWP in Q2 2017 and held it in 1 quarter. The position peaked at $744K in Q2 2017. 19 funds tracked by Wall St. Rank hold FWP as of Q3 2017.

  • Rhenman & Partners Asset Management reported no remaining Forward Pharma A/S American Depositary Shares position as of Q3 2017 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 5,226 Forward Pharma A/S American Depositary Shares shares in Q3 2017, an estimated $744K.
  • Rhenman & Partners Asset Management first reported a position in Forward Pharma A/S American Depositary Shares in Q2 2017 and held it in 1 quarter.
  • Rhenman & Partners Asset Management's Forward Pharma A/S American Depositary Shares position peaked at $744K in Q2 2017.
  • 19 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q3 2017.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.